Scott Michael Palmer, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Vice-Chair for Research in the Department of Medicine
Professor in Immunology
Core Faculty in Innovation & Entrepreneurship
Campus mail 2085 Msrb2 2 Genome Ct, Durham, NC 27710
Phone (919) 684-0245
Email address

Dr. Palmer leads a successful program of clinical, basic and translational research in transplantation and advanced lung diseases. He currently directs the pulmonary research program at the Duke Clinical Research Institute (DCRI) and serves as Vice Chair for Research in the Department of Medicine.

Dr. Palmer has over 150 peer reviewed publications, received numerous awards, including election into the American Society for Clinical Investigation (ASCI) in 2012, chaired many sessions at national and international meetings, serves regularly on NIH study sections, and is on the editorial board of many prominent journals. He is also Associate Director of the Clinical Research Training Program at Duke and has personally mentored over 40 pre-and post-doctoral trainees, many of whom are now engaged in their own successful research careers.

His scientific accomplishments include the first human studies to demonstrate the importance of innate immunity in transplant rejection and completion of a prospective multicenter study that improved CMV prevention after lung transplantation.

Current basic projects in the lab are studying the role of the matrix in the activation of innate immunity in pulmonary transplant rejection, and epithelial injury and repair in the development of toxin induced bronchiolitis obliterans. Translational and human projects are studying predictors of lung transplant survival in the UNOS database, immune monitoring to predict CMV infection and acute rejection after lung transplantation, and the use of novel inhaled antibiotics in lung transplantation. The lab is also using cutting edge whole exome genetic sequencing to identify genetic predictors of transplant rejection.

Dr. Palmer also leads trials coordinated through the DCRI that study the natural history and investigate new treatments for idiopathic pulmonary fibrosis (IPF), chronic lung transplant rejection, and posttransplant cytomegalovirus infection.

Education and Training

  • Fellow, Pulmonary Medicine, Medicine, Duke University, 1996 - 1999
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2000
  • M.D., Duke University, 1993


Hoffman, BM, Smith, PJ, Ingle, KK, Stonerock, GL, Saulino, C, Palmer, SM, Snyder, LD, Reynolds, JM, and Blumenthal, JA. "Coping And Clinical Outcomes Among Lung Transplant Patients." 2017.


Kelly, FL, Weinberg, KE, Nagler, AE, Brass, DM, Palmer, SM, and RCMB, . "Diacetyl-Induced Il-8 Production Is Mediated By EGFR And Erk 1/2 Activation In Pulmonary Epithelial Cells." 2017.


Nagler, AE, Kelly, FL, Weinberg, KE, Palmer, SM, and Brass, DM. "EGFR Ligands Increase Mek-Dependent Hyaluronan Synthesis In Naive Rat Lung Fibroblasts." 2017.


Weinberg, KE, Kelly, FL, Nagler, AE, Palmer, SM, and Brass, DM. "Nitrogen Mustard (mechlorethamine Hydrochloride) Induces Amphiregulin Shedding And Hyaluronan Synthesis In Human Epithelial Cells." 2017.


Todd, JL, Foster, MW, Valente, A, Brinkley, C, Ali, HA, Reynolds, JM, Kelly, FL, and Palmer, SM. "Proteomics Of Bronchoalveolar Lavage (bal) Fluid In Bronchiolitis Obliterans Syndrome (bos)." 2017.


Bates, CA, Frankel, CW, Gray, AL, Reynolds, JM, Palmer, SM, and Neely, ML. "Outcomes In Lung Transplant Recipients With Pulmonary Fibrosis At High Risk Of Death." 2017.


Todd, JL, Mikels-Vigdal, AJ, Kelly, FL, Pavlisko, EN, Mikaelian, I, O'Riordan, TG, Smith, VC, and Palmer, SM. "Loxl-2 Contributes To The Development Of Obliterative Bronchiolitis (ob) In Humans." 2017.


Hartwig, MG, Ganapathi, AM, Osho, AA, Hirji, SA, Englum, BR, Speicher, PJ, Palmer, SM, Davis, RD, and Snyder, LD. "Staging of Bilateral Lung Transplantation for High-Risk Patients With Interstitial Lung Disease: One Lung at a Time." American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 16, no. 11 (November 2016): 3270-3277.

Full Text

Podolanczuk, AJ, Oelsner, EC, Barr, RG, Hoffman, EA, Armstrong, HF, Austin, JHM, Basner, RC, Bartels, MN, Christie, JD, Enright, PL, Gochuico, BR, Hinckley Stukovsky, K, Kaufman, JD, Hrudaya Nath, P, Newell, JD, Palmer, SM, Rabinowitz, D, Raghu, G, Sell, JL, Sieren, J, Sonavane, SK, Tracy, RP, Watts, JR, Williams, K, Kawut, SM, and Lederer, DJ. "High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study." The European Respiratory Journal 48, no. 5 (November 2016): 1442-1452.

Full Text

Hubbs, AF, Fluharty, KL, Edwards, RJ, Barnabei, JL, Grantham, JT, Palmer, SM, Kelly, F, Sargent, LM, Reynolds, SH, Mercer, RR, Goravanahally, MP, Kashon, ML, Honaker, JC, Jackson, MC, Cumpston, AM, Goldsmith, WT, McKinney, W, Fedan, JS, Battelli, LA, Munro, T, Bucklew-Moyers, W, McKinstry, K, Schwegler-Berry, D, Friend, S, Knepp, AK, Smith, SL, and Sriram, K. "Accumulation of Ubiquitin and Sequestosome-1 Implicate Protein Damage in Diacetyl-Induced Cytotoxicity." The American Journal of Pathology 186, no. 11 (November 2016): 2887-2908.

Full Text